Participants
stroke, skeletal muscle diseases, IPF, Parkinson’s disease
KIDNEY DISEASE, STROKE, UIP, SKELETAL MUSCLE DISEASE, CHRONIC RESPIRATORY DISEASE, DISABLING DISEASE, DISEASES, COMPLICATIONS
All participants are stable IPF patients will be recruited from the Department of Respiratory Medicine at the First Affiliated Hospital of Jiangxi University of Traditional Chinese Medicine. Potential participants will be screened through the hospital’s clinical database to determine whether they will be contacted by phone or in-person for the study. All participants who signed the consent form will be evaluated by an assessor with their eyes covered. Participants who meet the relevant eligibility criteria will have their demographic, anthropometric, and questionnaire information recorded, and they will be randomly assigned to each group.Diagnosis of IPF will be confirmed according to the Global IPF Initiative (GOLD) standard. The criteria include: (1) Age between 35 and 80; (2) The clinical symptoms are stable in the last two months; (3) Patients diagnosed with IPF who satisfied the diagnostic criteria of ATS/ERS/JRS/ALAT 2018 [According to past medical history, laboratory tests and HRCT (typical UIP and Probable UIP)]; (4) Have not participated in systematic or intermittent training for another sport in the past six months (no more than twice a week); (5) No other disabling diseases (e.g. stroke, Parkinson’s disease, etc.); (6) Patients who agree to sign written informed consent.Among the exclusion criteria are the following: (1) other chronic respiratory diseases; (2) serious complications, such as cardiovascular, liver, or kidney disease; (3) in patients whose condition is rapidly deteriorating or urgently requiring other medication management; (4) skeletal muscle diseases or other diseases that may affect muscle strength assessment.